Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the objective response rate of oxaliplatin combined with 5-FU in patients with
recurrent or metastatic head and neck cancer and to assess the safety profile of these
treatment regimen.